FIGURE 1.
Progression‐free survival of HER2‐positive MBC patients treated with pyrotinib‐contained regimen (n = 172). MBC, metastatic breast cancer.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.